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Abstract
This study assessed the presence of influenza virus among young children and the coverage of vacci-
nation from 2010 to 2012 in São Paulo, Brazil. Our results demonstrated a lower rate of influenza de-
tection and a predominance of influenza B. A decrease of coverage vaccination through the
surveillance periods was observed.
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Young children have the immune response less robust
than in older children against influenza infection. In com-
munity studies, school-aged children have had the highest
rates of infection and disease. Prospective surveillance
studies of influenza illness in preschool- and school-aged
children demonstrate that annually, between 15% and 42%
of children are infected (Glezen and Couch, 1978; Neuzil et
al., 2002).
Infected children shed infectious virus for longer pe-
riods and at higher titers than adults do, which may explain
in part why children in child care and school play a central
role in the spread of virus in a community (Rennels and
Meissner, 2002).
Influenza infection has been associated with compli-
cations such as exacerbations of wheezing and asthma, in-
creased airway hyper-reactivity and hospitalization. Only
recently has it become fully appreciated that the risk of in-
fluenza-associated hospitalization for healthy young chil-
dren is similar to that for previously recognized high-risk
groups. They also appear to be at higher risk of hospitaliza-
tion from influenza than are healthy 50- to 64-year-olds, for
whom routine immunization has been recommended since
2000 (Barker and Mullooly, 1980; Izurieta et al., 2000;
Neuzil et al., 2000a; Neuzil et al., 2000b; Simonsen et al.,
2000; Neuzil et al., 2002).
The circulating influenza virus strains and their match
to vaccine strains and the timing and severity of the influ-
enza season vary annually. The current influenza vaccine
formulation contains 3 virus strains: A(H1N1), A(H3N2),
and only a B strain.
Most guidelines support the opinion that influenza
vaccination should be given to patients with asthma, in-
cluding children (Nicholson et al., 1995). The proportion of
children with asthma that is vaccinated varies widely and is
lower than in the older population (Kramarz et al., 2000).
The assessment of the disease burden over multiple
years, mainly on post-pandemic years, is needed to esti-
mate the impact of strategies of prevention on the burden of
influenza viruses beyond of determine the circulation pat-
tern of these viruses.
The goal of our study was to assess the presence of
influenza virus among symptomatic young children pre-
senting wheezing as well as the coverage of influenza vac-
cination from 2010 to 2012 in a region from the South
hemisphere.
Symptomatic children attended at an emergency
room of São Paulo Federal University/São Paulo Univer-
sity Hospital during the influenza season, with acute respi-
ratory infection of probable viral etiology were enrolled by
a pediatrician after the consent form was signed by the par-
ents or guardians. The inclusion criterion was: children
aged  5 years old presenting fever and wheezing up to 7
days. The Ethics Committee of São Paulo Federal Univer-
sity (CEP 0421/10) approved this study. Overall, 74 naso-
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pharyngeal swabs samples were collected. Nucleic acid
was extracted from 140 L of collected samples using the
QIAmp Viral RNA Extraction kit (Qiagen, Germany), ac-
cording to the manufacturer’s recommendations. For detec-
tion influenza A (seasonal and pandemic) and influenza B,
we performed the CDC Real-time PCR protocol for influ-
enza A (H1N1) pdm09 (CDC, 2009) with minor modifica-
tions. Primers used for detection of influenza B targeting
the NS gene segment (Selvaraju and Selvarangan 2010);
RnaseP was used as internal control. A total volume of
25 L was used for each reaction, containing 5 L of RNA
extracted, 0.8 M primer, 0.2 M probe, 1x RT-PCR En-
zyme Mix, 1x RT-PCR Buffer with AgPath-ID TM One Step
RT-PCR (Ambion, EUA) and Influenza A 2009 H1N1 As-
say Set v1.0 (Applied Biosystems, EUA) on a model ABI
7500 real-time. The reaction occurred under the following
conditions: 50 °C for 30 min, 95 °C for 10 min and 45 cy-
cles of 95 °C for 15 s and 55 °C for 30 s.
The average age of the patients included in the study
was 1 year old (range from 1 month to 5 years old). Out of
74 clinical samples enrolled in the study, 4 (5.4%) were
positive for influenza virus. All the 4 positive cases were
identified as influenza B virus and no influenza A detection
was found. The positive cases of influenza B infection were
registered only during 2011. Considering the total of pa-
tients who were included in the study during 2011, the in-
fluenza B infection rate was 10.2% (4/39).
The average age of influenza positive cases was 1.5
year old. Cough and coryza were the most common clinical
presentations of infected cases. Sore throat and diarrhea
were more reported among the influenza B positive cases
than the negative ones, with 50% and 25% respectively.
The influenza coverage vaccination rate among the 74 in-
vestigated subjects was 57.1%. Four out of 74 included
cases had no vaccination information. There was a decrease
on the vaccination rate through the surveillance period,
which 2010 was the year with the largest influenza vaccina-
tion coverage. The Table 1 shows the distribution of cover-
age vaccination on the surveillance years of the study.
On the 4 influenza B identified cases, two had re-
ceived the influenza vaccine during the years 2010 and
2011.
The Advisory Committee on Immunization Practices
(ACIP) of the Centers for Disease Control and Prevention
(CDC) recommends routine vaccination of children 6-23
months of age and has extended the recommendation to
children up to 5 years of age (Harper et al., 2005).
Our results showed a low rate of influenza positive
cases among children presenting fever and wheezing. This
data was probably influenced by a good rate of influenza
coverage vaccination, even among unvaccinated children,
once it should be considered the indirect herd effect from
vaccination, a phenomenon that offers potential for im-
proving the effectiveness of influenza prevention in the re-
maining unvaccinated population.
Studies have shown a major rate of influenza virus
detection among children aged up 5 years old than pre-
school aged children (Wu et al., 2010; Raboni et al., 2011).
Since influenza infection can lead to lower respiratory tract
infection and hospitalization, mainly on some risk group
patients, such as children presenting wheezing, the vaccina-
tion can play an important role on influenza infection pre-
vention and control among preschool- and school-aged
children.
The first period of our study revealed a higher rate of
influenza coverage vaccination decreasing through the next
seasons. Due to the influenza A (H1N1) pandemic in 2009,
there was a higher coverage of vaccination in 2010. How-
ever, during the post-pandemic influenza pandemic the
vaccine adherence decreased. The significant reduction on
influenza A (H1N1) pdm09 infection cases during 2010
may be related with a major concern due to the impact that
the first pandemic influenza wave (2009) played world-
wide. On the other hand, the inclusion of children aged up 2
years old in the Brazilian annual vaccination program on
influenza virus is recent. In this regard, the knowledge on
influenza virus season impact as well as the need of an an-
nual revaccination is not truly understood among the medi-
cal and non-medical community.
Our surveillance data showed influenza B detection
only in 2011 and we hypothesized that the post-pandemic
influenza wave may be influenced dynamic of influenza
different strains circulation.
In our study, we found two influenza B detections on
children who were vaccinated against influenza virus.
However, these two cases were not considered to be immu-
nized against influenza once they had been recently vacci-
nated and protective antibody titers are usually achieved
after two weeks of vaccination. In addition, the 2011-12 tri-
valent influenza vaccine contains a strain of influenza
B/Victoria-lineage viruses. Recently a study carried out on
Taiwan revealed a predomination by influenza B/Yama-
gata-lineage viruses occurred during the 2011-12 season
(Lo et al., 2013). Although our study was not directed to in-
vestigate the linage viruses on influenza positive cases, the
possibility of influenza B/Yamagata-lineage viruses should
be considered. In this regard, introducing a quadrivalent in-
fluenza vaccine that includes strains of both B lineages may
improve influenza control among young children.
The low incidence of influenza-infected cases ob-
served in the surveillance period may be considered a limi-
tation of our study.
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Table 1 - Influenza coverage vaccination on the surveillance years.




In conclusion, our study showed the impact of vacci-
nation on influenza virus circulation among young children
during 2010-2012 with a lower rate of influenza detection.
The decrease of vaccination coverage through the surveil-
lance periods supports the need to maintain programs to
stimulate vaccine adherence on children.
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